Delivery Order SPE2DB20D1100-SPE2DB25FE4B3
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $13,387.05 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on September 2, 2025, with an ultimate completion date of September 3, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Jardiance is a prescription medication used in diabetes management, representing one...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $19,582.52 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units). This competitive award, issued on July 22, 2025, with an ultimate completion date of July 23, 2025, represents a firm fixed-price delivery order with no set-aside designation. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and falls under the company's broader...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,017.88 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count) on September 2, 2025, with an ultimate completion date of September 3, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. Jardiance is a prescription diabetes medication commonly used in military and...
- The Defense Logistics Agency awarded a delivery order valued at $12,196.14 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Jardiance is a prescription medication used in diabetes management, representing...
- The Defense Logistics Agency awarded a delivery order valued at $2,387.27 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units). This contract, issued on August 15, 2025, with an ultimate completion date of August 18, 2025, represents a firm fixed-price delivery order with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Jardiance is a diabetes medication commonly used within...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count) on July 24, 2025, with an ultimate completion date of July 25, 2025. This competitively awarded, non-set-aside contract is valued at $1,807.80 and utilizes firm fixed price terms. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate office and primary distribution...
- The Defense Logistics Agency awarded a delivery order valued at $5,162.13 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on August 18, 2025, with an ultimate completion date of August 19, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Jardiance is a diabetes medication commonly used in military and...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) under a firm fixed-price contract valued at $4,976.53. The award, issued on July 29, 2025, with an ultimate completion date of July 30, 2025, represents a non-set-aside competitive procurement. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $29,954.01 on July 18, 2025, for the supply of Jardiance 25 mg tablets (90-count packages). This firm fixed-price, competitively awarded contract represents a non-set-aside delivery order with an ultimate completion date of July 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Jardiance is a diabetes management medication, consistent with...
- The Defense Logistics Agency awarded a delivery order valued at $5,240.80 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count) on July 22, 2025, with an ultimate completion date of July 23, 2025. This firm fixed price delivery order represents a non-competitive procurement and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Jardiance is a diabetes medication commonly used in military and federal healthcare systems to...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE4B3Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $113,093.48 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units). This firm fixed-price delivery order, issued on September 2, 2025, with an ultimate completion date of September 3, 2025, represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Jardiance is a diabetes medication commonly used in federal military and veteran healthcare systems, aligning with the DLA's mission to supply pharmaceutical products across the Defense Health Agency and related government medical programs. This delivery order is executed under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare operations globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a significant federal contracting presence focused on delivering brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support military readiness and veteran healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $113.1k | 9/2/25 |